To assess the contribution of IL-21 and IL-7 to antitumor immunity as potential vaccine adjuvants, transduced B16F10 melanoma cell lines expressing either of the two cytokines alone or together were put to test in a prophylactic B16F10 model, along with the control cell line. Here, IL21 is linked to melanoma.